Integer Holdings Corporation Common Stock (ITGR)
72.72
+0.38 (0.53%)
NYSE · Last Trade: Dec 13th, 4:00 AM EST
NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · December 12, 2025
Law Offices of Howard G. Smith announces an investigation on behalf of Integer Holdings Corporation (“Integer” or the “Company”) (NYSE: ITGR) investors concerning the Company’s possible violations of federal securities laws.
By Law Offices of Howard G. Smith · Via Business Wire · December 12, 2025
The Law Offices of Frank R. Cruz announces an investigation of Integer Holdings Corporation (“Integer” or the “Company”) (NYSE: ITGR) on behalf of investors concerning the Company’s possible violations of federal securities laws.
By The Law Offices of Frank R. Cruz · Via Business Wire · December 12, 2025
NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Integer Holdings Corporation (“Integer” or the “Company”) (NYSE: ITGR) between July 25, 2024 through October 22, 2025, inclusive (collectively, the “Class Period”).
By Bernstein Liebhard LLP · Via GlobeNewswire · December 12, 2025
PHILADELPHIA, Dec. 12, 2025 (GLOBE NEWSWIRE) --
By Grabar Law Office · Via GlobeNewswire · December 12, 2025
Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Integer Holdings Corporation (NYSE: ITGR) securities between July 25, 2024 and October 22, 2025. Integer is a leading global medical device contract manufacturer specializing in cardiac rhythm management and cardiovascular products.
By Robbins LLP · Via Business Wire · December 11, 2025
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until February 9, 2026 to file lead plaintiff applications in a securities class action lawsuit against Integer Holdings Corporation (“Integer” or the “Company”) (NYSE: ITGR), if they purchased or otherwise acquired the Company’s shares between July 25, 2024 and October 22, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
By Kahn Swick & Foti, LLC · Via Business Wire · December 11, 2025
Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of Integer Holdings Corporation (NYSE: ITGR) common stock between July 25, 2024 and October 22, 2025, both dates inclusive (the “Class Period”). Integer is a medical device contract manufacturer.
By The Rosen Law Firm, P.A. · Via Business Wire · December 11, 2025
Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Integer Holdings Corporation (NYSE: ITGR) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws.
By Bleichmar Fonti & Auld LLP · Via Business Wire · December 11, 2025
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Integer Holdings Corporation (“Integer” or the “Company”) (NYSE: ITGR) investors concerning the Company’s possible violations of the federal securities laws.
By Glancy Prongay & Murray LLP · Via Business Wire · December 11, 2025

A growth strategy that includes both in-house expansion and acquisition activity could keep Integer Holdings Corporation's run going well into 2024.
Via MarketBeat · November 7, 2023

~ Strategic transaction to meaningfully reduce interest expense ~~ Immediately earnings accretive in 2023 ~
By Integer Holdings Corporation · Via GlobeNewswire · February 3, 2023

PLANO, Texas, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (the “Company,” “Integer”) (NYSE: ITGR) today announced that it has priced an offering of $435 million aggregate principal amount of 2.125% convertible senior notes due 2028 (the “Convertible Notes”). The offering was upsized from the previously announced offering size of $375 million aggregate principal amount of Convertible Notes. The Company granted to the initial purchasers of the Convertible Notes an option to purchase up to an additional $65 million aggregate principal amount of the Convertible Notes for settlement within a 13-day period beginning on, and including, the first day on which the Convertible Notes are issued. The offering is expected to close on February 3, 2023, subject to customary closing conditions.
By Integer Holdings Corporation · Via GlobeNewswire · January 31, 2023

~ Preliminary fourth quarter 2022 sales increase of 18% to 19% versus 2021 ~~ Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call ~
By Integer Holdings Corporation · Via GlobeNewswire · January 30, 2023

PLANO, Texas, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (the “Company,” “Integer”) (NYSE: ITGR) today announced that it intends to offer, subject to market and other conditions, $375 million aggregate principal amount of its convertible senior notes due 2028 (the “Convertible Notes”).
By Integer Holdings Corporation · Via GlobeNewswire · January 30, 2023

SAN JOSE, Calif., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (“Eargo” or the “Company”) (Nasdaq: EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced the appointments of several new directors following the closing of the Company’s rights offering as previously announced on November 29, 2022. Patient Square Capital became the Company’s majority owner upon closing of the rights offering and conversion of Patient Square’s senior secured convertible notes per its investment in June 2022.
By Eargo Inc · Via GlobeNewswire · December 7, 2022
San Diego, CA -- (SBWIRE) -- 04/27/2021 -- Certain directors of Integer Holdings Corporation are under investigation over potential breaches of fiduciary duties.
Via SBWire · April 27, 2021
